July 14, 2014

Sandoz on Monday announced the introduction of tobramycin inhalation solution, USP into the U.S. market. The drug is an authorized generic version of Tobi from Novartis.

July 14, 2014

Re-introducing a type of polio vaccine that fell out of favour in the 1960s could hasten eradication of the disease, according to new research.

July 14, 2014

Teva Pharmaceuticals on Monday announced that the Food and Drug Administration has accepted the company's new drug application for albuterol multi-dose dry-powder inhaler, a breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease.

July 14, 2014

Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules.

July 14, 2014

Walgreens on Monday expanded vaccine availability at all of its more than 800 locations across Florida as new state legislation takes effect to help bring greater patient access to vaccines.

July 11, 2014

Breg on Thursday announced the launch of the FreeRunner knee brace with new innovations to help people, particularly runners, who suffer from patella mal-tracking return to active lifestyles.

July 11, 2014

Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.

July 11, 2014

The Pharmacy Quality Alliance has developed and launched a new quality measurement initiative, aimed at narrowing gaps in measurement and reporting for adult immunizations.

July 11, 2014

CVS/pharmacy replaced single-ingredient pseudoephedrine products with the tamper-resistant PSE product, Zephrex-D, in all of its West Virginia stores, as well as stores in nearby states that are located within 15 miles of West Virginia's border, including Kentucky, Maryland, Ohio, Pennsylvania and Virginia.

 

With the move, West Virginia has become a de facto test market for the diversion-defiant PSE formulation, because along with CVS/pharmacy, Rite Aid and Fruth and soon Walgreens will all be selling similar formulations. The move sends a stern message to West Virginian methamphetamine makers to the tune of Tom Petty's "Don't come around here no more."

July 10, 2014

Alliance Labs on Wednesday announced the launch of DocuSol Kids, a non-irritating constipation solution. 

July 10, 2014

Lift, smooth, de-wrinkle and firm. This is the desired effect of not only facial anti-agers, but also those formulas for the body, as aging women yearn to turn back the hands of time below the neck.

July 10, 2014

Ateb on Thursday announced it has reached an agreement to license Walgreens' entire portfolio of prescription alignment patents in an effort to continue to improve overall health care, demonstrate the value of medication synchronization and increase patient adherence rates.

July 10, 2014

With community pharmacies being called on to provide a wider range of services, drug stores across the country are adapting new technologies to ensure that they can meet the evolving needs of their patients and strengthen their role in the nation’s healthcare system.

July 10, 2014

Skin care brand derma e has announced the launch of its new Stretch Mark Crème.

July 10, 2014

The Food and Drug Administration in late June issued a warning letter to Zarbee's for making therapeutic claims regarding a dietary supplement product.

July 10, 2014

The summer months continue to bring hot weather and — when you add summer rainfall to the mix — bothersome mosquitos.

July 10, 2014

Insight Pharamceuticals on Wednesday announced the launch of a new suite of products — Monistat Complete Care — that offers women solutions to maintain their vaginal health.

July 10, 2014

Overall, the intimacy health category generated more than $870 million in sales, trending up in the low single-digits. Sales of condoms, the largest piece of the business, totaled $380.7 million across total U.S. multi-outlets for the 52 weeks ended April 20, and was down slightly by 1.8%. The growth is coming out of the personal lubricant ($213.4 million, up 2.9%) and emergency contraceptive ($253.2 million, up 12.3%) sectors.

July 10, 2014

A wave of new drug introductions and healthcare policy changes has had a significant impact on women’s health care over the past year.

July 10, 2014

A survey co-released by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that 8-in-10 healthcare providers have serious concerns about a proposed Food and Drug Administration rule on generic drug labeling.

July 10, 2014

The same weather factors that are boosting allergy sales as the allergy season is extended may be having a substantial impact on the sales of anti-itch ointments, up 10% to $528.2 million across U.S. multi-outlets for the 52 weeks ended April 20, according to IRI, and insect bite treatments, which totaled $13.6 million and were up 19.4% over the same period.

July 10, 2014

The Office of National Drug Control Policy released the 2014 National Drug Control Strategy, the Obama Administration’s primary blueprint for drug policy in the United States.

July 10, 2014

VoicePort on Thursday announced a patent licensing agreement with Walgreens that covers 11 U.S. patents and patent applications owned by Walgreens in the field of prescription alignment.

July 9, 2014

GelStat on Tuesday announced it has closed the acquisition of Mastix Medica.